Skip to main content

Table 4 Antimicrobial susceptibility among Gram-positive isolates including multi-drug resistance(MDR) strains from blood specimens collected between 2012 and 2016

From: Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial

 

Africa

Asia

Europe

North America

Latin America

Global

Global

S%

S%

S%

S%

S%

MIC90(mg/L)

MIC range(mg/L)

S%

R%

MIC90(mg/L)

MIC range(mg/L)

S%

R%

 

S.aureus

S.aureus, all isolates

MRSA

N = 43

N = 298

N = 2008

N = 814

N = 161

N = 3324

N = 1096

Levofloxacin

65.1

57.4

69.3

67.3

77.0

16

0.06–64

68.1

30.2

64

0.06–64

21.9

75.6

Linezolid

100.0

100.0

100.0

100.0

100.0

2

0.5–4

100.0

0.0

2

0.5–4

100.0

0.0

Minocycline

83.7

97.3

99.5

98.3

100.0

0.25

0.25–16

98.8

0.1

0.5

0.25–16

97.5

0.1

Penicillin

2.3

6.0

15.9

16.6

8.1

16

0.06–16

14.7

85.4

16

0.12–16

0.1

99.9

Tigecycline

100

99.7

100.0

100.0

100.0

0.12

0.008–1

99.9

0.0

0.25

0.015–1

99.9

0.0

Vancomycin

100.0

100.0

100.0

100.0

100.0

1

0.12–2

100.0

0.0

1

0.12–2

100.0

0.0

 

E.faecalis

E.faecalis, all isolates

VR E.faecalis

N = 26

N = 99

N = 910

N = 406

N = 86

N = 1527

N = 22

Ampicillin

100.0

96.0

98.9

99.8

96.5

1

0.06–32

98.8

1.2

32

0.5–32

86.4

13.6

Levofloxacin

69.2

70.7

68.6

73.4

81.4

64

0.06–64

70.7

28.5

64

0.5–64

13.6

86.4

Linezolid

100.0

97.0

100.0

100.0

97.7

2

0.5–8

99.7

0.1

2

0.5–2

100.0

0.0

Minocycline

30.8

35.4

36.8

35.2

38.4

8

0.25–16

36.3

6.3

8

0.25–8

27.3

0.0

Penicillin

100.0

95.0

98.8

99.8

96.5

4

0.06–16

98.7

1.3

16

2–16

86.4

13.6

Tigecycline

100.0

100.0

99.9

100.0

100.0

0.12

0.008–0.5

100.0

0.0

0.12

0.03–0.12

100.0

0.0

Vancomycin

96.2

98.0

99.0

96.6

98.8

2

0.12–64

98.2

1.4

64

32–64

0.0

100.0

 

E.faecium

E.faecium, all isolates

VR E.faecium

N = 9

N = 89

N = 603

N = 268

N = 31

N = 1000

N = 276

Ampicillin

11.1

12.4

11.1

14.2

6.5

32

0.06–32

11.9

88.1

32

4–32

0.7

99.3

Levofloxacin

22.2

9.0

9.8

12.3

12.9

64

0.06–64

10.6

87.0

64

8–64

0.0

100.0

Linezolid

100.0

100.0

99.7

98.8

100.0

2

0.5–8

99.5

0.2

2

0.5–8

98.9

0.4

Minocycline

88.9

47.2

70.2

59.0

80.7

8

0.25–16

65.6

6.2

8

0.25–16

58.7

6.2

Penicillin

11.1

14.6

13.1

12.7

6.5

16

0.06–16

12.9

87.1

16

4–16

1.5

98.6

Tigecycline

100.0

100.0

99.5

98.9

100.0

0.12

0.008–1

99.4

0.0

0.12

0.008–1

98.9

0.0

Vancomycin

66.7

78.7

87.1

38.1

41.9

64

0.12–64

71.6

27.6

64

32–64

0.0

100.0

 

S.pneumoniae

S.pneumoniae, all isolates

PR S.pneumoniae

N = 23

N = 66

N = 1248

N = 553

N = 93

N = 1983

N = 178

Amoxy/clav

91.3

95.5

98.0

96.2

93.6

1

0.03–16

97.1

1.1

8

0.03–16

68.5

11.8

Azithromycin

69.6

38.1

81.1

63.0

44.6

64

0.03–512

72.7

26.0

128

0.03–512

28.7

69.0

Ceftriaxone

100.0

94.0

98.7

99.0

98.9

0.5

0.03–8

98.6

0.1

2

0.03–8

86.0

1.1

Clarithromycin

69.6

39.7

80.9

63.0

69.6

128

0.015–128

73.9

26.0

128

0.015–128

30.5

69.0

Clindamycin

78.3

61.9

85.3

87.4

79.4

128

0.015–128

84.7

14.8

128

0.015–128

53.5

45.4

Erythromycin

69.6

39.7

80.8

63.6

69.6

64

0.015–128

74.0

25.8

128

0.015–128

29.9

69.0

Levofloxacin

100.0

98.5

99.6

99.6

98.9

1

0.06–16

99.6

0.4

1

0.12–16

99.4

0.6

Linezolid

100.0

100.0

100.0

100.0

100.0

1

0.5–2

100.0

0.0

1

0.5–2

100.0

0.0

Meropenem

81.0

60.6

89.7

87.0

86.0

0.5

0.12–8

87.8

7.1

1

0.12–8

3.4

70.8

Minocycline

73.9

37.9

77.5

83.7

69.9

4

0.25–16

77.5

16.8

8

0.25–16

46.1

45.0

Penicillin

69.6

34.9

70.4

69.8

55.9

1

0.06–16

68.3

9.0

4

2–16

0.0

100.0

Tigecycline

100.0

98.5

99.8

99.5

100.0

0.03

0.008–4

99.7

0.0

0.03

0.008–0.12

100.0

0.0

Vancomycin

100.0

100.0

100.0

100.0

100.0

0.5

0.12–1

100.0

0.0

0.5

0.12–1

100.0

0.0

 

S.agalactiae

 

N = 8

N = 64

N = 505

N = 373

N = 32

N = 982

 

Ampicillin

100.0

100.0

100.0

100.0

100.0

0.12

0.06–0.25

100.0

0.0

    

Ceftriaxone

100.0

100.0

100.0

100.0

100.0

0.12

0.03–0.5

100.0

0.0

    

Levofloxacin

100.0

95.3

98.2

96.5

87.5

1

0.06–64

97.1

2.7

    

Linezolid

100.0

100.0

100.0

100.0

100.0

1

0.5–2

100.0

0.0

    

Meropenem

100.0

100.0

100.0

100.0

100.0

0.12

0.12–0.5

100.0

0.0

    

Minocycline

12.5

20.3

17.8

22.0

50.0

16

0.25–16

20.6

62.7

    

Penicillin

100.0

100.0

100.0

100.0

100.0

0.12

0.06–0.12

100.0

0.0

    

Tigecycline

100.0

96.9

99.8

100.0

100.0

0.06

0.008–4

99.7

0.0

    

Vancomycin

100.0

100.0

100.0

100.0

100.0

0.5

0.12–1

100.0

0.0

    
  1. Abbreviations: S% percentage of susceptible isolates, R% percentage of resistant isolates, MIC minimum inhibitory concentration, Amoxy/clav Amoxicillin/clavulanic acid